Skip to content

Clinical trials

Completed Phase 1 Respiratory Syncytial Virus Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Syncytial Virus Infections Phase: Phase 1 Status: Completed Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20072
20102
20114
20121
20139
20147
20153
20162
20175
20188
20192
20204
20215
20224
20232
20246
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed70

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)16
Enanta Pharmaceuticals, Inc9
GlaxoSmithKline5
Pfizer5
Ablynx, a Sanofi company3
Alios Biopharma Inc.3
MedImmune LLC3
MicroDose Therapeutx, Inc3
Sanofi Pasteur, a Sanofi Company3
Meissa Vaccines, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Syncytial Virus Infections70
Bronchiolitis1
Paramyxoviridae Infections1
Respiratory Tract Infections1
Virus Diseases1

Trials

Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.